Home » Topics » BioWorld Science

BioWorld Science
RSS

Arcturus receives additional support from CF Foundation to develop mRNA therapies to treat CF

Aug. 5, 2019

IDMC recommends stopping PHOCUS study of Pexa-Vec

Aug. 2, 2019

T20K demonstrates favorable safety and tolerability in first-in-human study

Aug. 2, 2019

Recruitment ongoing in phase I study of BI-754132

Aug. 2, 2019

Novartis initiates first-in-human trial of CD19-specific CAR-T cells

Aug. 2, 2019

Prokaryotics receives support for its immune potentiation program

Aug. 2, 2019

First patient dosed in phase IIa study of ABX-464 for the treatment of RA

Aug. 2, 2019

New glucose-lowering compounds presented by Daiichi Sankyo

Aug. 2, 2019

Aurigene Discovery Technologies describes new anticancer agents

Aug. 2, 2019

Integral BioSciences discloses new TGFR-1 and MAPK14 inhibitors

Aug. 2, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026